Scientific Sessions 2025  /  Innovation in Quality – Heart Failure  /  Transforming Treatment in ATTR-CM
Logo

American Heart Association

  22
  0

Final ID:

Transforming Treatment in ATTR-CM

  • Maurer, Mathew  ( Columbia University , New York , New York , United States )
    • Author Disclosures:
    Mathew Maurer: DO have relevant financial relationships ; Advisor:Pfizer:Active (exists now) ; Advisor:Intellia:Active (exists now) ; Advisor:BrigdeBio:Active (exists now) ; Advisor:AstraZeneca:Active (exists now) ; Advisor:Ionis:Active (exists now) ; Advisor:Alnylam:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Innovation in Quality – Heart Failure

Monday, 11/10/2025 , 09:45AM - 11:00AM

Special Focus

More abstracts on this topic:
Improving Heart Failure Outcomes through Quality Indicators & Nurse-Led Patient Engagement

Jordan Rios Antonio

Focus on Heart Failure Patients with Preserved and Mildly Reduced EF

Chahoud Georges

More abstracts from these authors:
AL Cardiac Amyloidosis: A High Risk, High Reward Condition with Contemporary Treatment

Maurer Mathew, Witteles Ronald

5 Key Lessons learned about Cardiac Amyloidosis in the last 10 years and what remains to be learned. 10 minutes

Maurer Mathew, Ambardekar Amrut

You have to be authorized to contact abstract author. Please, Login
Not Available